Michael Rousseau - St Jude Insider

STJ -- USA Stock  

USD 80.82  0.13  0.16%

  CEO
Mr. Michael T. Rousseau was appointed as President Chief Executive Officer Director of the Company. effective January 1 2016. He was Chief Operating Officer of St. Jude Medical Inc. Mr. Rousseau joined St. Jude Medical in 1999 as Senior Vice President Cardiac Rhythm Management Global Marketing and later that year CRM marketing and sales were combined under his leadership. In January 2008 he was promoted to Group President and assumed responsibility for the company four product divisions. He was named Chief Operating Officer in 2014 overseeing global sales marketing technology development operations supply chain and quality functions
Age: 59  CEO Since 2016      
651 756-3301  www.sjm.com
Rousseau has helped to drive strategic transformation across virtually every area of the company. He was the architect of St. Jude Medical recent, significant integration of four product divisions into centralized global functions with a shared global vision, mission and growth strategy based on accelerating innovation. During this time and under Mr. Rousseau leadership, St. Jude Medical has achieved significant costsavings and operational efficiencies. He led the realignment of global supply chain management, restructured the company overseas manufacturing, and established a global quality system to put a global infrastructure in place to prepare the company for future growth. Recognizing the changing customer landscape, he broadened the company global customer service operations with a focus to enhance the experience for St. Jude Medical customers worldwide.

Michael Rousseau Latest Insider Activity

Management Efficiency

The company has Return on Asset of 0.08 % which means that on every $100 spent on asset it made $0.08 of profit. This is way below average.
The company has 6.39 B in debt with debt to equity (D/E) ratio of 1.29 which is OK given its current industry classification. St Jude Medical has Current Ratio of 1.89 which is typical for the industry and considered as normal.

Similar Executives

Found 9 records

CEO Since

Timothy DamadianFonar Corporation
2016
Roger SusiIRadimed Corporation
2016
Doris ZhouIonix Technology
2015
Patrick SullivanInsulet Corporation
2016
Locksley SamuelsIonix Technology
2015
Shane EbertSurge Holdings
2016
Dow WilsonVarian Medical Systems
2012
Keith ValentineSeaSpine Holdings Corporation
2015
Kenneth FerryiCAD
2015

Entity Summary

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical (STJ) is traded on New York Stock Exchange in USA. It is located in One St. Jude Medical Drive, St. Paul, MN 55117, United States and employs 18,000 people.

St Jude Medical Leadership Team

David Lamb, Managing Director, Executive Director
Baroness Wheatcroft, Non-Executive Independent Director
Ian Gascoigne, Managing Director, Executive Director
John Heinmiller, Executive VP
Tony Dunk, Director - Investor Relations
Denis Gestin, President of International Division
Craig Gentle, CFO
Stephan Widensohler, Independent Director
Donald Zurbay, CFO and VP of Fin.
Lisa Andrade, Chief Marketing Officer
Wendy Yarno, Independent Director
Iain Cornish, Senior Independent Non-Executive Director
Richard Devenuti, Independent Director
Sarah Bates, Non-Executive Chairman of the Board
Jeffrey Dallager, Vice President Corporate Controller
Joel Becker, President - Americas Division
Stuart Essig, Independent Director
Andrew Croft, CFO, Executive Director
Barbara Hill, Independent Director
David Bellamy, Chief Executive, Executive Director
Roger Yates, Independent Non-Executive Director
John Brown, Independent Presiding Director
Daniel Starks, Executive Chairman
Eric Fain, Group President - St. Jude Medical
Elizabeth Kelly, Company Secretary
Rachel Ellingson, Vice President - Corporate Relations
Mark Carlson, Vice President - Global Clinical Affairs, Chief Medical Officer
Paul Bae, Chief Marketing Officer, Vice President - Global Human Resources
Michael Rousseau, CEO and President COO and Director
Mark Murphy, CIO and VP of Information Technology
Scott Thome, Vice President - Global Operations and Supply Chain
Michael Rocca, Independent Director
Simon Jeffreys, Independent Non-Executive Director
Jeff Fecho, Vice President - Global Quality
Jason Zellers, Vice President General Counsel, Corporate Secretary
J Weigelt, Director - Investor Relations
David Dvorak, Director
Stefan Widensohler, Independent Director

Stock Performance Indicators

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Price Transformation
Currently Active Assets on Macroaxis
CRM   
Purchased a lot of shares of
a day ago
Traded for 156.0
CRM   
Purchased a lot of shares of
a day ago
Traded for 156.0
F   
Purchased over 300 shares of
a day ago
Traded for 9.81
C   
Purchased over 40 shares of
a day ago
Traded for 74.735
GM   
Purchased over 70 shares of
a day ago
Traded for 36.08
Also please take a look at World Market Map. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com